Mean platelet volume in patients with non-alcoholic fatty liver disease

References

• Schreuder TC, Verwer BJ, van Nieuwkerk CM, Mulder CJ. Nonalcoholic fatty liver disease: An overview of current insights in pathogenesis, diagnosis and treatment. World J Gastroenterol 2008; 14: 2474–2486
   PubMed Web of Science ®Google Scholar
• Saadeh S, Younossi ZM. The spectrum of nonalcoholic fatty liver disease: From steatosis to nonalcoholic steatohepatitis. Cleve Clin J Med 2000; 67: 96–97
   PubMedGoogle Scholar
• Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, Omatsu T, Nakajima T, Sarui H, Shimazaki M, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005; 143: 722–728
   PubMed Web of Science ®Google Scholar
• Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 2001; 50: 1844–1850
   PubMed Web of Science ®Google Scholar
• Sattar N, Scherbakova O, Ford I, O'Reilly DS, Stanley A, Forrest E, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the West of Scotland Coronary Prevention Study. Diabetes 2004; 53: 2855–2860
   PubMed Web of Science ®Google Scholar
• Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB, Jr, Haffner SM. Liver markers and development of the metabolic syndrome. The Insulin Resistance Atherosclerosis Study. Diabetes 2005; 54: 3140–3147
   Google Scholar
• Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP. Platelets as predictors of vascular risk: Is there a practical index of platelet activity?. Clin Appl Thromb Hemost 2003; 9: 177–190
   PubMed Web of Science ®Google Scholar
• Pizzulli L, Yang A, Martin JF, Luderitz B. Changes in platelet size and count in unstable angina compared tostable angina or non-cardiac chest pain. Eur Heart J 1998; 19: 80–84
   PubMed Web of Science ®Google Scholar
• Jagroop IA, Mikhailidis DP. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2003; 120: 169–170
   PubMed Web of Science ®Google Scholar
• Wieckowska A, Feldstein AE. Diagnosis of nonalcoholic fatty liver disease: Invasive versus noninvasive. Semin Liver Dis. 2008; 28: 386–395
   PubMed Web of Science ®Google Scholar
• Angelico F, Del Ben M, Conti R, Francioso S, Feole K, Fiorello S, Cavallo MG, Zalunardo B, Lirussi F, Alessandri C, et al. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2005; 90: 1578–1582
   PubMedGoogle Scholar
• Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, et al. Nonalcoholic fattyliver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917–923
   PubMed Web of Science ®Google Scholar
• Mirbagheri SA, Rashidi A, Abdi S, Saedi D, Abouzari M. Liver: An alarm for the heart?. Liver Int 2007; 27: 891–894
   PubMedGoogle Scholar
• Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, Day C, Arcaro G. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007; 30: 1212–1218
   PubMed Web of Science ®Google Scholar
• Targher G, Bertolini L, Rodella S, Tessari R, Zenari L, Lippi G, Arcaro G. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care 2007; 30: 2119–2121
   PubMed Web of Science ®Google Scholar
• Thompson CB, Jakubowski JA. The pathophysiology and clinical relevance of platelet heterogeneity. Blood 1998; 72: 1–8
   Google Scholar
• Martin JF, Trowbridge EA, Salmon G, Plumb J. The biological significance of platelet volume: Its relationship to bleeding time, thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983; 32: 443–460
   PubMed Web of Science ®Google Scholar
• Sewell R, Ibbotson RM, Philips R. High mean platelet volume after myocardial infarction: Is it due to consumption of small platelets?. Br Med J 1984; 289: 1576–1580
   PubMed Web of Science ®Google Scholar
• Coban E, Bostan F, Ozdogan M. The mean platelet volume in subjects with impaired fasting glucose. Platelets 2006; 17: 67–69
   PubMed Web of Science ®Google Scholar
• Coban E, Ozdogan M, Yazicioglu G, Akcit F. The mean platelet volume in patients with obesity. Int J Clin Pract 2005; 59: 981–982
   PubMed Web of Science ®Google Scholar
• Kong AP, Choi KC, Cockram CS, Ho CS, Chan MH, Ozaki R, Wong GW, Ko GT, So WY, Tong PC, et al. Independent associations of alanine aminotransferase (ALT) levels with cardiovascular risk factor clustering in Chinese adolescents. J Hepatol. 2008; 49: 115–122
   PubMed Web of Science ®Google Scholar
• Wang CC, Lin SK, Tseng YF, Hsu CS, Tseng TC, Lin HH, Wang LY, Kao JH. Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2009; 24: 1411–1416
   PubMedGoogle Scholar